Candriam SCA’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6.06M | Buy |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $5.06M | Sell |
|
|||||
|
2023
Q2 | $5.37M | Buy |
|
|||||
|
2023
Q1 | $3.7M | Sell |
|
|||||
|
2022
Q4 | $11.5M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.88M | Sell |
|
|||||
|
2021
Q3 | $2.83M | Hold |
|
|||||
|
2021
Q2 | $3.14M | Buy |
|
|||||
|
2021
Q1 | $2.39M | Hold |
|
|||||
|
2020
Q4 | $2.49M | Sell |
|
|||||
|
2020
Q3 | $3.06M | Sell |
|
|||||
|
2020
Q2 | $3.94M | Buy |
|
|||||
|
2020
Q1 | $434K | Hold |
|
|||||
|
2019
Q4 | $444K | Hold |
|
|||||
|
2019
Q3 | $455K | Hold |
|
|||||
|
2019
Q2 | $381K | Buy |
|